SGHS - CAMDEN CAMPUS — History
CCN 110146 | 3-year financial timeline | COVID resilience: 28/100
🛡️ Public data only — no PHI permitted on this instance.
$55M
Latest Revenue (FY2022)
-3.7%
Revenue CAGR (3yr)
-10.3%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $59M | $67M | $55M | -17.5% | -3.7% |
| Operating Expenses | $55M | $65M | $61M | -6.1% | +5.1% |
| Operating Margin | 7.3% | 3.1% | -10.3% | -433.9% | +0.0% |
| Net Income | $4M | $2M | $-6M | -375.4% | +0.0% |
| Licensed Beds | 40 | 40 | 40 | +0.0% | +0.0% |
| Total Patient Days | 9,143 | 8,740 | 6,261 | -28.4% | -17.2% |
| Medicare Day % | 21% | 18% | 15% | -12.0% | -13.7% |
| Medicaid Day % | 4% | 6% | 8% | +35.3% | +33.3% |
COVID Impact & Recovery
Resilience Score: 28/100 — Distressed — significant COVID damage
Revenue recovery from FY2020 to FY2022: -7.2% ($59M → $55M)
FY2020 captured the initial COVID shock. Slow recovery suggests structural challenges beyond COVID.
Trend Summary
Revenue▼ Declining
Operating Margin▼ Declining
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
-3.7%
This Hospital
+7.6%
State Avg
Latest Margin
-10.3%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $53M | -19.2% |
| FY2024 (proj) | $51M | -28.0% |
| FY2025 (proj) | $49M | -36.8% |